Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Jun;176(6):696-8.
doi: 10.7205/milmed-d-10-00345.

Botulinum toxin type A for nonsurgical lateral release in patellofemoral pain syndrome: a case study

Affiliations
Case Reports

Botulinum toxin type A for nonsurgical lateral release in patellofemoral pain syndrome: a case study

David F Drake et al. Mil Med. 2011 Jun.

Abstract

Setting: Outpatient rehabilitation clinic.

Patient: A 37-year-old physically active male.

Case description: The patient presented with anterior left knee pain, exacerbated when climbing stairs, sitting, and running. Exam showed lateral tracking patellae and palpable crepitus. One hundred fifty units of botulinum toxin A was injected into his left vastus lateralis. He underwent a 12-week home exercise program targeting the vastus medialis (VM). ASSESSMENT/RESULTS: Visual analog scale decreased from 70 to 0 on a 150-mm scale, from initial until 8 weeks postinjection. Functional Index Questionnaire increased from 5 to 16 over the same period. Knee torque and surface electromyography findings showed increased activity of the VM during knee extension.

Conclusion: Botulinum injection into the vastus lateralis in conjunction with VM strengthening may provide more effective treatment of patellofemoral pain syndrome. Further study is needed to explore this novel treatment of patellofemoral pain syndrome.

PubMed Disclaimer

Publication types

Substances